Reyes Financial Architecture, Inc.

Position in GTBP — GT Biopharma, Inc.

CIK 2047201 SAN DIEGO, CA

Position in GTBP

as of Jun 30, 2026 · filed Jul 17, 2026 Compact

Position Value

$306

New position

Shares Held

625

first reported quarter

Ownership

0.002%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#15

of 16 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Reyes Financial Architecture, Inc. holds $129,824 across 5 Biotechnology names. GTBP ranks #4 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EXEL	Exelixis, Inc.	1,624	$88,361
2	KRYS	Krystal Biotech, Inc.	100	$37,167
3	VRTX	Vertex Pharmaceuticals Inc / Ma	8	$3,973
4	GTBP	GT Biopharma, Inc. This page	625	$306
5	CLDI	Calidi Biotherapeutics, Inc.	100	$17

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$306	625	—	Shares	Sole	2026-07-17
No filing history on record for this holder in this stock.